semaglutide conversion to tirzepatide Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are Switching from Semaglutide to Tirzepatide:

Treatment with semaglutide tablets 7 mg and 14 mg once daily for 26 weeks resulted in a statistically significant reduction in HbA1c from baseline compared to placebo once daily (see Table 9)

Lipotropic injections are thought to provide an extra edge for people working towards specific weight loss goals by aiding the bodys natural capacity to use sugar and fats as energy sources

Promotes Fat Loss: Encourages the body to use fat as an energy source, helping reduce fat stores

Pyruvate kinase M2 regulates Hif-1 activity and IL-1 induction and is a critical determinant of the warburg effect in LPS-activated macrophages